RFP
TEVA icon

Root Financial Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Root Financial Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.5K Buy
714
+45
+7% +$1.45K ﹤0.01% 1287
2025
Q4 		$20.9K Buy
669
+18
+3% +$443 ﹤0.01% 1170
2025
Q3 		$13.2K Buy
+651
New +$11.4K ﹤0.01% 1322

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Root Financial Partners's TEVA Position: Q1 2026 in Review

Root Financial Partners increased its Teva Pharmaceuticals (TEVA) stake by 6.7% in Q1 2026, buying an estimated $1.45K and bringing the position to 714 shares worth $21.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

Root Financial Partners first reported a position in TEVA in Q3 2025 and has held it in 3 quarters since. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Root Financial Partners held 714 shares of Teva Pharmaceuticals worth $21.5K as of Q1 2026.
  • Root Financial Partners bought 45 Teva Pharmaceuticals shares in Q1 2026, an estimated $1.45K.
  • Teva Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #1287 holding.
  • Root Financial Partners first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.